Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms

References

1. 1.↵
   2. Naidech AM,
   3. Drescher J,
   4. Tamul P, et al

   . Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006;77:1340–44 doi:10.1136/jnnp.2006.089748 pmid:16820419

   Abstract/FREE Full Text
2. 2.↵
   2. van Gijn J,
   3. Kerr RS,
   4. Rinkel GJ

   . Subarachnoid haemorrhage. Lancet 2007;369:306–18 doi:10.1016/S0140-6736(07)60153-6 pmid:17258671

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Kassell NF,
   3. Sasaki T,
   4. Colohan AR, et al

   . Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562–72 doi:10.1161/01.STR.16.4.562 pmid:3895589

   Abstract/FREE Full Text
4. 4.↵
   2. Platz J,
   3. Guresir E,
   4. Vatter H, et al

   . Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe? Neurocrit Care 2011;14:168–75 doi:10.1007/s12028-011-9510-2 pmid:21286853

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Frontera JA,
   3. Fernandez A,
   4. Schmidt JM, et al

   . Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009;40:1963–68 doi:10.1161/STROKEAHA.108.544700 pmid:19359629

   Abstract/FREE Full Text
6. 6.↵
   2. Kimball MM,
   3. Velat GJ,
   4. Hoh BL

   . Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care 2011;15:336–41 doi:10.1007/s12028-011-9600-1 pmid:21761272

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Albanese E,
   3. Russo A,
   4. Quiroga M, et al

   . Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience—clinical article. J Neurosurg 2010;113:913–22 doi:10.3171/2009.9.JNS0997 pmid:19877802

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Biondi A,
   3. Ricciardi GK,
   4. Puybasset L, et al

   . Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 2004;25:1067–76 pmid:15205150

   Abstract/FREE Full Text
9. 9.↵
   2. Hängg D,
   3. Turowski B,
   4. Beseoglu K, et al

   . Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. AJNR Am J Neuroradiol 2008;29:1053–60 doi:10.3174/ajnr.A1005 pmid:18372422

   Abstract/FREE Full Text
10. 10.↵
    2. Komotar RJ,
    3. Zacharia BE,
    4. Otten ML, et al

    . Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches. Neurosurgery 2008;62:897–905; discussion 905–897 doi:10.1227/01.neu.0000318175.05591.c3 pmid:18496195

    CrossRefPubMed
11. 11.↵
    2. Dankbaar JW,
    3. de Rooij NK,
    4. Rijsdijk M, et al

    . Diagnostic threshold values of cerebral perfusion measured with computed tomography for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2010;41:1927–32 doi:10.1161/STROKEAHA.109.574392 pmid:20689085

    Abstract/FREE Full Text
12. 12.↵
    2. Beck J,
    3. Raabe A,
    4. Lanfermann H, et al

    . Tissue at risk concept for endovascular treatment of severe vasospasm after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2004;75:1779–81 doi:10.1136/jnnp.2004.036921 pmid:15548506

    Abstract/FREE Full Text
13. 13.↵
    2. Beck J,
    3. Raabe A,
    4. Lanfermann H, et al

    . Effects of balloon angioplasty on perfusion- and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg 2006;105:220–27 doi:10.3171/jns.2006.105.2.220 pmid:17219826

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Vatter H,
    3. Güresir E,
    4. Berkefeld J, et al

    . Perfusion-diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2011;82:876–83 doi:10.1136/jnnp.2010.219592 pmid:21436228

    Abstract/FREE Full Text
15. 15.↵
    2. Vergouwen MD,
    3. Ilodigwe D,
    4. Macdonald RL

    . Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924–29 doi:10.1161/STROKEAHA.110.597914 pmid:21311062

    Abstract/FREE Full Text
16. 16.↵
    2. Janssen PM,
    3. Visser NA,
    4. Dorhout Mees SM, et al

    . Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis 2010;29:137–39 doi:10.1159/000262309 pmid:19955737

    CrossRefPubMed
17. 17.↵
    2. Shimoda M,
    3. Takeuchi M,
    4. Tominaga J, et al

    . Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery 2001;49:1341–48; discussion 1348–50 doi:10.1097/00006123-200112000-00010 pmid:11846933

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Hunt WE,
    3. Hess RM

    . Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14–20 doi:10.3171/jns.1968.28.1.0014 pmid:5635959

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Fisher CM,
    3. Kistler JP,
    4. Davis JM

    . Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9 doi:10.1227/00006123-198001000-00001 pmid:7354892

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Aburto-Murrieta Y,
    3. Marquez-Romero JM,
    4. Bonifacio-Delgadillo D, et al

    . Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Vasc Endovasc Surg 2012;46:460–65 doi:10.1177/1538574412454585 pmid:22914892

    Abstract/FREE Full Text
21. 21.↵
    2. John S,
    3. Spiotta AM,
    4. Turner RM, et al

    . Initial experience with the coaxial dual-lumen Scepter C balloon catheter for endovascular management of cerebral vasospasm from subarachnoid hemorrhage. J Neurointerv Surg 2014;6:125–28 doi:10.1136/neurintsurg-2012-010572 pmid:23371937

    Abstract/FREE Full Text
22. 22.↵
    2. Santillan A,
    3. Knopman J,
    4. Zink W, et al

    . Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2011;69:95–101; discussion 102 doi:10.1227/NEU.0b013e31821424f9 pmid:21368694

    CrossRefPubMed
23. 23.↵
    2. Wolf S,
    3. Martin H,
    4. Landscheidt JF, et al

    . Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care 2010;12:346–51 doi:10.1007/s12028-009-9317-6 pmid:20033353

    CrossRefPubMed
24. 24.↵
    2. Mortimer AM,
    3. Steinfort B,
    4. Faulder K, et al

    . Institution of sustained endovascular treatment prior to clinical deterioration in patients with severe angiographic vasospasm: A retrospective observational study of clinico-radiological outcomes. J Neuroradiol 2015;42:176–83 doi:10.1016/j.neurad.2014.12.002 pmid:25649394

    CrossRefPubMed
25. 25.↵
    2. Jun P,
    3. Ko NU,
    4. English JD, et al

    . Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010;31:1911–16 doi:10.3174/ajnr.A2183 pmid:20616179

    Abstract/FREE Full Text
26. 26.↵
    2. Pandey P,
    3. Steinberg GK,
    4. Dodd R, et al

    . A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion. Neurosurgery 2012;71(1 suppl operative):77–85 doi:10.1227/NEU.0b013e3182426257 pmid:22105209

    CrossRefPubMed
27. 27.↵
    2. Zwienenberg-Lee M,
    3. Hartman J,
    4. Rudisill N, et al

    ; Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke 2008;39:1759–65 doi:10.1161/STROKEAHA.107.502666 pmid:18420953

    Abstract/FREE Full Text
28. 28.↵
    2. Doukas A,
    3. Petridis AK,
    4. Barth H, et al

    . Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. Acta Neurochir Suppl 2011;112:93–96 doi:10.1007/978-3-7091-0661-7_16 pmid:21691994

    CrossRefPubMed
29. 29.↵
    2. Musahl C,
    3. Henkes H,
    4. Vajda Z, et al

    . Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Neurosurgery 2011;68:1541–47; discussion 1547 doi:10.1227/NEU.0b013e31820edd46 pmid:21311378

    CrossRefPubMed
30. 30.↵
    2. Feng L,
    3. Fitzsimmons BF,
    4. Young WL, et al

    . Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 2002;23:1284–90 pmid:12223366

    Abstract/FREE Full Text
31. 31.↵
    2. Keuskamp J,
    3. Murali R,
    4. Chao KH

    . High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;108:458–63 doi:10.3171/JNS/2008/108/3/0458 pmid:18312091

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Rosenwasser RH,
    3. Armonda RA,
    4. Thomas JE, et al

    . Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975–79; discussion 979–80 doi:10.1097/00006123-199905000-00022 pmid:10232530

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Khatri R,
    3. Memon MZ,
    4. Zacharatos H, et al

    . Impact of percutaneous transluminal angioplasty for treatment of cerebral vasospasm on subarachnoid hemorrhage patient outcomes. Neurocrit Care 2011;15:28–33 doi:10.1007/s12028-010-9499-y pmid:21360234

    CrossRefPubMed
34. 34.↵
    2. Pandey AS,
    3. Elias AE,
    4. Chaudhary N, et al

    . Endovascular treatment of cerebral vasospasm: vasodilators and angioplasty. Neuroimaging Clin N Am 2013;23:593–604 doi:10.1016/j.nic.2013.03.008 pmid:24156852

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Rahme R,
    3. Jimenez L,
    4. Pyne-Geithman GJ, et al

    . Endovascular management of posthemorrhagic cerebral vasospasm: indications, technical nuances, and results. Acta Neurochir Suppl 2013;115:107–12 doi:10.1007/978-3-7091-1192-5_23 pmid:22890655

    CrossRefPubMed
36. 36.↵
    2. Hui C,
    3. Lau KP

    . Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 2005;60:1030–36 doi:10.1016/j.crad.2005.04.004 pmid:16124986

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Firat MM,
    3. Gelebek V,
    4. Orer HS, et al

    . Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol 2005;26:1357–62 pmid:15956497

    Abstract/FREE Full Text
38. 38.↵
    2. Hoh BL,
    3. Ogilvy CS

    . Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005;16:501–16, vi pmid:15990041

    CrossRefPubMed
39. 39.↵
    2. McDougall CG,
    3. Spetzler RF,
    4. Zabramski JM, et al

    . The Barrow Ruptured Aneurysm Trial. J Neurosurg 2012;116:135–44 doi:10.3171/2011.8.JNS101767 pmid:22054213

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Spetzler RF,
    3. McDougall CG,
    4. Albuquerque FC, et al

    . The Barrow Ruptured Aneurysm Trial: 3-year results. J Neurosurg 2013;119:146–57 doi:10.3171/2013.3.JNS12683 pmid:23621600

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Spetzler RF,
    3. McDougall CG,
    4. Zabramski JM, et al

    . The Barrow Ruptured Aneurysm Trial: 6-year results. J Neurosurg 2015;123:609–17 doi:10.3171/2014.9.JNS141749 pmid:26115467

    CrossRefPubMed
42. 42.↵
    2. Molyneux A,
    3. Kerr R,
    4. Stratton I, et al

    ; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74 doi:10.1016/S0140-6736(02)11314-6 pmid:12414200

    CrossRefPubMedWeb of Science
43. 43.↵
    2. Molyneux AJ,
    3. Kerr RS,
    4. Birks J, et al

    ; ISAT Collaborators. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009;8:427–33 doi:10.1016/S1474-4422(09)70080-8 pmid:19329361

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Molyneux AJ,
    3. Kerr RS,
    4. Yu LM, et al

    ; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809–17 doi:10.1016/S0140-6736(05)67214-5 pmid:16139655

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Darsaut TE,
    3. Jack AS,
    4. Kerr RS, et al

    . International Subarachnoid Aneurysm Trial-ISAT, Part II: study protocol for a randomized controlled trial. Trials 2013;14:156 doi:10.1186/1745-6215-14-156 pmid:23714335

    CrossRefPubMed
46. 46.↵
    2. Pegoli M,
    3. Mandrekar J,
    4. Rabinstein AA, et al

    . Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 2015;122:414–18 doi:10.3171/2014.10.JNS14290 pmid:25495745

    CrossRefPubMed
47. 47.↵
    2. Hänggi D,
    3. Etminan N,
    4. Macdonald RL, et al

    . NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage. Neurocrit Care 2015;23:274–84 doi:10.1007/s12028-015-0112-2 pmid:25678453

    CrossRefPubMed
48. 48.↵
    2. Taufique Z,
    3. May T,
    4. Meyers E, et al

    . Predictors of poor quality of life 1 year after subarachnoid hemorrhage. Neurosurgery 2016;78:256–56 doi:10.1227/NEU.000000000000104284 pmid:26421590

    CrossRefPubMed
49. 49.↵
    2. Dodel R,
    3. Winter Y,
    4. Ringel F, et al

    . Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke 2010;41:2918–23 doi:10.1161/STROKEAHA.110.586826 pmid:21071720

    Abstract/FREE Full Text
50. 50.↵
    2. Sehba FA,
    3. Hou J,
    4. Pluta RM, et al

    . The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 2012;97:14–37 doi:10.1016/j.pneurobio.2012.02.003 pmid:22414893

    CrossRefPubMed
51. 51.↵
    2. Fergusen S,
    3. Macdonald RL

    . Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2007;60:658–67; discussion 667 pmid:17415202

    PubMedWeb of Science
52. 52.↵
    2. Rosengart AJ,
    3. Huo JD,
    4. Tolentino J, et al

    . Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007;107:253–60 doi:10.3171/JNS-07/08/0253 pmid:17695377

    CrossRefPubMedWeb of Science
53. 53.↵
    2. Bederson JB,
    3. Connolly ES Jr.,
    4. Batjer HH, et al

    ; American Heart Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994–1025 doi:10.1161/STROKEAHA.108.191395 pmid:19164800

    FREE Full Text
54. 54.↵
    2. Dorhout Mees SM,
    3. Rinkel GJ,
    4. Feigin VL, et al

    . Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007:CD000277 pmid:17636626
55. 55.↵
    2. Rabinstein AA,
    3. Lanzino G,
    4. Wijdicks EF

    . Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol 2010;9:504–19 doi:10.1016/S1474-4422(10)70087-9 pmid:20398858

    CrossRefPubMedWeb of Science
56. 56.↵
    2. Budohoski KP,
    3. Czosnyka M,
    4. Kirkpatrick PJ, et al

    . Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol 2013;9:152–63 doi:10.1038/nrneurol.2013.11 pmid:23419369

    CrossRefPubMed